Literature DB >> 314923

Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

H S Shukla, R H Whitehead, L E Hughes.   

Abstract

The relationship between tumour load and immunity in gastrointestinal cancer has been studied by sequential comparison in patients whose tumour has been removed and those whose tumour was found to be inoperable. Total lymphocyte count, absolute and percentage T- and B-lymphocyte counts, effect of papain on E-rosetting cell levels, and inhibitory effect of cancer sera on E-rosette formation by normal lymphocytes have been studied in 30 patients with stomach or colorectal cancer, and 10 control patients with benign gastrointestinal disease. The examination was done on each patient before and at regular intervals after operation up to 24 weeks. Operable cases, with removal of tumour load, showed a temporary fall in total lymphocyte count and T cell counts, which returned to normal by four weeks postoperatively. Inoperable cases (15 patients) showed a progressive fall in total lymphocyte count and a relatively greater depression of T cell counts, in parallel with increasing tumour mass. E-receptor blocking factor was demonstrated in the sera of cancer patients. This factor was related to tumour mass and presumably was of tumour origin, as it persisted in the inoperable group but disappeared by 12 weeks after tumour removal. The factor explained the excess depresion of T cells over total lymphocytes, but does not explain the continuing depression of total lymphocyte count in the cancer patients.

Entities:  

Mesh:

Year:  1979        PMID: 314923      PMCID: PMC1412545          DOI: 10.1136/gut.20.8.660

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance.

Authors:  H M Anthony; J A Kirk; K E Madsen; M K Mason; G H Templeman
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

2.  Decreased T-lymphocytes in patients with mammary cancer.

Authors:  S E Keller; H L Ioachim; T Pearse; D M Siletti
Journal:  Am J Clin Pathol       Date:  1976-04       Impact factor: 2.493

3.  Disturbed immune reactions following surgery.

Authors:  P R Riddle
Journal:  Br J Surg       Date:  1967-10       Impact factor: 6.939

4.  A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.

Authors:  A P McLaughlin; J D Brooks
Journal:  J Urol       Date:  1974-09       Impact factor: 7.450

5.  Reduced lymphocyte transformation in breast cancer.

Authors:  M G Whittaker; K Rees; C G Clark
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

6.  Proceedings: Cellular immunity in cured cancer patients.

Authors:  P L Twomey; W J Catalona; P B Chretien
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

7.  Masking of receptors for sheep erythrocytes on human T-lymphocytes by sera from breast cancer patients.

Authors:  R H Whitehead; G P Roberts; J Thatcher; C Teasdale; L E Hughes
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

8.  Letter: Plasmapheresis and immunostimulation.

Authors:  O Browne; J Bell; P D Holland; R D Thornes
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

9.  T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro.

Authors:  R H Whitehead; J Thatcher; C Teasdale; G P Roberts; L E Hughes
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

10.  Importance of methodology in demonstrating depression of T-lymphocyte levels.

Authors:  R H Whitehead; G P Roberts; L E Hughes; J Thatcher
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

View more
  1 in total

1.  The importance of protease histochemistry in pathology.

Authors:  Z Lojda
Journal:  Histochem J       Date:  1985-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.